Revascularization in complex multivessel coronary artery disease after FREEDOM. Is there an indication for PCI and
1Department of Cardiology, Bern University Hospital, 3010, Bern, Switzerland.
Insights
For diabetic patients with coronary artery disease, coronary artery bypass grafting (CABG) is preferred for complex cases, but percutaneous coronary interventions (PCI) with drug-eluting stents (DES) are a viable option for select individuals. Treatment decisions require personalized strategies.
Area of Science:
- Cardiology
- Diabetology
- Vascular Medicine
Background:
- Diabetes mellitus is a common metabolic disorder linked to coronary atherosclerosis.
- Myocardial revascularization is crucial for managing diabetic patients with coronary artery disease.
Purpose of the Study:
- To review indications for myocardial revascularization in diabetic patients.
- To discuss current evidence and future perspectives on CABG versus PCI in this population.
Main Methods:
- Review of current literature and clinical trial data.
- Critical analysis of revascularization strategies (CABG vs. PCI) in diabetic patients.
Main Results:
- CABG is generally the preferred method for complex, multivessel disease in diabetics.
- New-generation DES offer a valuable alternative for selected diabetic patients.
- Tailored approaches are essential, considering patient-specific factors and procedural risks.
Conclusions:
- Advances in DES technology may improve PCI outcomes in diabetic patients.
- Ongoing randomized trials will further clarify the comparative effectiveness of PCI versus CABG.
- Personalized treatment strategies are key for optimizing revascularization in diabetic patients.
Abstract:
Diabetes mellitus is a highly prevalent metabolic disorder frequently associated with the development of coronary atherosclerosis. Myocardial revascularization assumes a central role in the treatment of diabetic patients with coronary artery disease. Although coronary artery bypass grafting (CABG) is in principle the revascularization modality of choice in diabetic patients with complex, multivessel disease, percutaneous coronary interventions (PCI) using new-generation drug-eluting stents (DES) remain a valuable treatment option for properly selected diabetic patients. Defining the appropriate revascularization strategy is often a challenging task that requires tailored approaches, accounting for individual patient surgical risk, anatomical configurations, and the technical feasibility of each procedure in addition to careful judgment of the possible benefits and risks inherent to PCI and CABG. Evidence is building that advances in DES technology may mitigate at least in part some of the adverse vascular effects of diabetes; whether this may translate to PCI outcomes comparable with those achieved by CABG is under investigation in randomized trials currently underway. This review article summarizes the indications for myocardial revascularization across the spectrum of clinical presentations and critically discusses current evidence and future perspectives regarding the value of each revascularization mode (CABG vs. PCI) in patients with diabetes.
Related Concept Videos
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:26Atherosclerosis III: Management
01:30Coronary Artery Disease I: Introduction
01:24Cardiac Catheterization III: Left Heart Catheterization
01:30Acute Coronary Syndrome I: Introduction
01:17Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...